Value of 3D Modeling in Spine Surgery
Launched by COLUMBIA UNIVERSITY · May 12, 2016
Trial Information
Current as of May 28, 2025
Terminated
Keywords
ClinConnect Summary
The biplanar low-dose EOS system and its associated spineEOS workstation (EOS®, EOS Imaging, Paris, France) allows 3D spine reconstructions. The EOS system presents some advantages over MRI or CT Scans. The weight bearing position allows assessment in the functional position and the radiation exposure is 800-1000 times less then CT scans, allowing full spine acquisition even in pediatric patients. Selected anatomical landmarks are utilized to reconstruct a 3D model of the spine allowing global assessment as well as localized analysis.The aim of the study is to assess the clinical relevance ...
Gender
ALL
Eligibility criteria
- • Adults --
- Inclusion Criteria:
- • All patients must be age 18 or greater at the time of surgery or initial consultation
- • Having a primary surgery of their spine (fusion or instrumentation)
- Exclusion Criteria:
- • Diagnosis of scoliosis other than degenerative or idiopathic (i.e., paralytic/neuromuscular, congenital)
- • Undergoing revision (fusion or instrumentation)
- EOS Exclusion Criteria:
- • Patients with supernumerary vertebrae (one extra or one less thoracic or lumbar vertebrae)
- • Insufficient quality of images to perform the 3D modeling with spineEOS software
- • Children --
- Inclusion Criteria:
- • All patients must be younger than 18 at the time of surgery
- • Having a primary surgery of their spine (fusion or instrumentation)
- Exclusion Criteria:
- • Diagnosis of scoliosis other than degenerative or idiopathic (i.e., paralytic/neuromuscular, congenital
- • Undergoing revision (fusion or instrumentation)
- EOS Exclusion Criteria:
- • Patients with supernumerary vertebrae (one extra or one less thoracic or lumbar vertebrae)
- • Insufficient quality of images to perform the 3D modeling with spineEOS software
About Columbia University
Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Lawrence G Lenke, MD
Principal Investigator
Columbia University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials